Litcius/Paper detail

14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study

Virak Eng, Dysoley Lek, Sitha Sin, Lionel Brice Feufack-Donfack, Ágnes Orbán, Jeremy Salvador, Dynang Seng, S. Heng, Nimol Khim, Kieran Tebben, Claude Flamand, Cécile Sommen, Rob W. van der Pluijm, Michael White, Benoît Witkowski, David Serre, Jean Popovici

2025The Lancet Infectious Diseases11 citationsDOIOpen Access PDF

Topics & Concepts

PrimaquineMedicinePlasmodium vivaxOpen labelVivax malariaMalariaInternal medicinePlasmodium falciparumClinical trialImmunologyChloroquineMalaria Research and ControlVector-borne infectious diseasesCoccidia and coccidiosis research